222 studies found for:    nasopharyngeal cancer | "Nasopharyngeal Neoplasms"
Show Display Options
Download search resultsDownload the search results for:
nasopharyngeal cancer | "Nasopharyngeal Neoplasms" (222 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: EBV-LMP-2
2 Completed Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Sorafenib plus Cisplatin and 5-fluorouracil
3 Completed Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function
Condition: Nasopharyngeal Neoplasms
Intervention: Procedure: Intensity-modulated radiation therapy
4 Unknown  Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
Conditions: Nasopharyngeal Neoplasms;   Carcinoma, Squamous Cell
Interventions: Procedure: Conventional RT;   Drug: Cisplatin;   Drug: 5-fluorouracil
5 Recruiting Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: gemcitabine and cisplatin;   Drug: 5-Fluorouracil and cisplatin
6 Terminated Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)
Conditions: Nasopharyngeal Neoplasms;   Carcinoma, Squamous Cell
Interventions: Procedure: Conventional RT;   Procedure: Accelerated RT;   Drug: Cisplatin;   Drug: 5-fluorouracil
7 Not yet recruiting Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
Condition: Nasopharyngeal Neoplasms
Interventions: Procedure: Conventional Radiotherapy;   Procedure: Accelerated Radiotherapy;   Drug: Cisplatin;   Drug: 5-fluorouracil;   Drug: Capecitabine
8 Active, not recruiting Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: ABX + DDP
9 Completed
Has Results
Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents
Conditions: Nasopharyngeal Neoplasms;   Carcinoma
Interventions: Drug: docetaxel (Taxotere®, XRP6976);   Drug: cisplatin;   Drug: 5-fluorouracil (5-FU)
10 Completed Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Pemetrexed (Alimta)
11 Unknown  Intensity Modulated Radiation Therapy for Head and Neck Cancer
Condition: Nasopharyngeal Neoplasms
Interventions: Procedure: intensity modulated radiation therapy;   Drug: cisplatinium and fluorouracil - standard treatment
12 Completed Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin
13 Recruiting Environmental and Genetic Determinants of NPC
Conditions: Nasopharyngeal Neoplasms;   Herpesvirus 4, Human
Intervention:
14 Completed Taxotere + Cisplatin in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Docetaxel;   Drug: Cisplatin
15 Unknown  Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Oxaliplatin
16 Recruiting The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Cisplatin;   Drug: Paclitaxel;   Radiation: IMRT
17 Recruiting A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens
Conditions: Nasopharyngeal Neoplasms;   Salivary Gland Diseases;   Bone Marrow Diseases;   Mucositis
Interventions: Drug: Amifostine every-other-day regimen;   Drug: Amifostine everyday regimen
18 Not yet recruiting The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma
Condition: Effects of Chemotherapy
Interventions: Drug: Concurrent chemotherapy with cisplatin;   Radiation: Intensity modulated radiotherapy
19 Unknown  Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer
Condition: Advanced Nasopharyngeal Cancer
Interventions: Drug: Nimotuzumab;   Drug: placebo plus chemoradiotherapy
20 Completed EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)
Conditions: Nasopharyngeal Cancer;   EBV Infections
Interventions: Biological: EBV specific CTL Infusion;   Biological: Anti CD45 monoclonal antibody

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years